Cardiac biomarkers: myths, facts and future horizons

Measurement of Stiffness Index by Digital Volume Pulse Analysis Technique: Clinical Utility in Cardiovascular Disease Risk Stratification

“…5 Hence, there is a need for novel risk markers (or biomarkers) which are capable of directly examining the underlying pathophysiological processes for refining risk stratification and the early identification of younger high-risk populations. 6 To be clinically useful in the prediction of CVD, novel techniques should be closely related to the existing prediction methods. In addition, they should also provide an additional value to the existing methods in risk assessment.…”